COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination

The incidence of COVID-19 infection in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) is similar to that in the general population, but the mortality rate is much higher. COVID-19 vaccination is strongly recommended for PAH/CTEPH patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieteska-Miłek, Maria, Szmit, Sebastian, Florczyk, Michał, Kuśmierczyk-Droszcz, Beata, Ryczek, Robert, Kurzyna, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706780/
https://www.ncbi.nlm.nih.gov/pubmed/34960141
http://dx.doi.org/10.3390/vaccines9121395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706780/
https://www.ncbi.nlm.nih.gov/pubmed/34960141
http://dx.doi.org/10.3390/vaccines9121395

Ejemplares similares